156 related articles for article (PubMed ID: 23741889)
21. Oral zinc in recurrent Erythema Nodosum Leprosum reaction.
Mathur NK; Bumb RA; Mangal HN
Lepr India; 1983 Jul; 55(3):547-52. PubMed ID: 6656212
[TBL] [Abstract][Full Text] [Related]
22. Methotrexate in resistant ENL.
Kar BR; Babu R
Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):480-2. PubMed ID: 15755203
[TBL] [Abstract][Full Text] [Related]
23. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.
Upputuri B; Pallapati MS; Tarwater P; Srikantam A
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008678. PubMed ID: 33035210
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic Dilemma of Refractory Erythema Nodosum Leprosum.
Zhu J; Yang D; Shi C; Jing Z
Am J Trop Med Hyg; 2017 Jun; 96(6):1362-1364. PubMed ID: 28719256
[TBL] [Abstract][Full Text] [Related]
25. Erythema Nodosum Leprosum: Update and challenges on the treatment of a neglected condition.
Costa PDSS; Fraga LR; Kowalski TW; Daxbacher ELR; Schuler-Faccini L; Vianna FSL
Acta Trop; 2018 Jul; 183():134-141. PubMed ID: 29474830
[TBL] [Abstract][Full Text] [Related]
26. [Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy].
Rodríguez G; Pinto R; López F; Gómez Y
Biomedica; 2009 Mar; 29(1):18-24. PubMed ID: 19753835
[TBL] [Abstract][Full Text] [Related]
27. ENLIST 1: An International Multi-centre Cross-sectional Study of the Clinical Features of Erythema Nodosum Leprosum.
Walker SL; Balagon M; Darlong J; Doni SN; Hagge DA; Halwai V; John A; Lambert SM; Maghanoy A; Nery JA; Neupane KD; Nicholls PG; Pai VV; Parajuli P; Sales AM; Sarno E; Shah M; Tsegaye D; Lockwood DN;
PLoS Negl Trop Dis; 2015; 9(9):e0004065. PubMed ID: 26351858
[TBL] [Abstract][Full Text] [Related]
28. Necrotic erythema nodosum leprosum with oral mucosal involvement.
Swain JP; Soud A; Agarwal SK
Indian J Lepr; 2008; 80(2):175-8. PubMed ID: 19425513
[TBL] [Abstract][Full Text] [Related]
29. A Traditional NSAID Aspirin along with Clofazimine in Erythema Nodosum Leprosum Reaction: Study of Six Cases.
Sharma PK; Singh DK
Indian J Lepr; 2016 Sep; 87(4):249-253. PubMed ID: 29762954
[TBL] [Abstract][Full Text] [Related]
30. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
Becx-Bleumink M; Berhe D
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
[TBL] [Abstract][Full Text] [Related]
31. Concomitant lucio phenomenon and erythema nodosum in a leprosy patient: clues for their distinct pathogeneses.
Benard G; Sakai-Valente NY; Bianconcini Trindade MA
Am J Dermatopathol; 2009 May; 31(3):288-92. PubMed ID: 19384072
[TBL] [Abstract][Full Text] [Related]
32. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
[TBL] [Abstract][Full Text] [Related]
33. Reactional states in multibacillary Hansen disease patients during multidrug therapy.
Nery JA; Vieira LM; de Matos HJ; Gallo ME; Sarno EN
Rev Inst Med Trop Sao Paulo; 1998; 40(6):363-70. PubMed ID: 10436656
[TBL] [Abstract][Full Text] [Related]
34. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum.
Sharma NL; Sharma V; Shanker V; Mahajan VK; Sarin S
Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):483-5. PubMed ID: 15755204
[TBL] [Abstract][Full Text] [Related]
35. Clofazimine in lepra (ENL) reaction, one year clinical trial.
Burte NP; Chandorkar AG; Muley MP; Balsara JJ; Bulakh PM
Lepr India; 1983 Apr; 55(2):265-77. PubMed ID: 6355652
[TBL] [Abstract][Full Text] [Related]
36. Thalidomide levels in patients with erythema nodosum leprosum.
Vieira JL; Valente Mdo S
Ther Drug Monit; 2009 Oct; 31(5):602-3. PubMed ID: 19704404
[TBL] [Abstract][Full Text] [Related]
37. The effect of anti-reactional drugs on complement components in the type II, erythema nodosum leprosum, reaction.
Sehgal VN; Sharma V; Sharma VK
Br J Dermatol; 1988 Aug; 119(2):255-8. PubMed ID: 3166944
[TBL] [Abstract][Full Text] [Related]
38. The effects of prednisolone treatment on serological responses and lipid profiles in Ethiopian leprosy patients with Erythema Nodosum Leprosum reactions.
Negera E; Tilahun M; Bobosha K; Lambert SM; Walker SL; Spencer JS; Aseffa A; Dockrell HM; Lockwood DN
PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007035. PubMed ID: 30592714
[TBL] [Abstract][Full Text] [Related]
39. Response to treatment by multidrug regimens in the THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
Lepr Rev; 1996 Dec; 67(4):260-79. PubMed ID: 9033197
[TBL] [Abstract][Full Text] [Related]
40. Serum immunoglobulins an autoantibodies during and after erythema nodosum leprosum (ENL).
Sharma VK; Saha K; Sehgal VN
Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):159-63. PubMed ID: 6811448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
